Neural repair and neuroprotection with stem cells in ischemic stroke

Brain Sciences

Volumn 3, Issue 2, 2013, Pages 599-614

  Stone, Laura L ^a,b   Grande, Andy ^a,b   Low, Walter C ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Ischemia; Ischemic brain injury; Neuroprotection; Stem cells; Stroke

Indexed keywords

CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL RESEARCH; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; MOTOR PERFORMANCE; NEOVASCULARIZATION (PATHOLOGY); NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEIZURE; STEM CELL TRANSPLANTATION; SUBDURAL HEMATOMA;

EID: 84922735742     PISSN: None     EISSN: 20763425     Source Type: Journal    
DOI: 10.3390/brainsci3020599     Document Type: Review

References (62)

1. Roger, V.; Go, A.; Lloyd-Jones, S.; Benjamin, E.; Berry, J.; Borden, W.; Bravata, D.; Dai, S.; Ford, E.; Fox, C.; et al. Heart disease and stroke statistics-2012 update: A report from the american heart association. Circulation 2012, 125, e2-e220.
2. Donnan, G.A.; Howells, D.W.; Markus, R.; Toni, D.; Davis, S.M. Can the time window for the administration of thrombolytics in stroke be increased? CNS Drugs 2003, 17, 995-1011.
3. Bose, A.; Henkes, H.; Alfke, K.; Reith, W.; Mayer, T.E.; Berlis, A.; Branca, V.; Po Sit, S. The penumbra system: A mechanical device for the treatment of acute stroke due to thromboembolism. Am. J. Neuroradiol. 2008, 29, 1409-1413.
4. Kim, D.; Jahan, R.; Starkman, S.; Abolian, A.; Kidwell, C.S.; Vinuela, F.; Duckwiler, G.R.; Ovbiagele, B.; Vespa, P.M.; Selco, S.; et al. Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. Am. J. Neuroradiol. 2006, 27, 2048-2052.
5. Jahan, R. Solitaire flow-restoration device for treatment of acute ischemic stroke: Safety and recanalization efficacy study in a swine vessel occlusion model. Am. J. Neuroradiol. 2010, 31, 1938-1943.
6. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 1995, 333, 1581-1587.
7. Colucci-D'Amato, L.; Bonavita, V.; Di Porzio, U. The end of the central dogma of neurobiology: Stem cells and neurogenesis in adult CNS. Neurol. Sci. 2006, 27, 266-270.
8. Altman, J.; Das, G. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 1965, 124, 319-335.
9. Nottebohm, F. From bird song to neurogenesis. Sci. Am. 1989, 260, 74-79.
10. Doetsch, F. A niche for adult neural stem cells. Curr. Opin. Genet. Dev. 2003, 13, 543-550.
11. Parent, J.M. Injury-induced neurogenesis in the adult mammalian brain. Neuroscientist 2003, 4, 261-272.
12. Weiss, S.; Reynolds, B.; Vescovi, A.; Morshead, C.; Craig, C.; van der Kooy, D. Is there a neural stem cell in the mammalian forebrain? Trends Neurosci. 1996, 19, 387-393.
13. Liu, J.; Solway, K.; Messing, R.O.; Sharp, F.R. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 1998, 18, 7768-7778.
14. Arvidsson, A.; Collin, T.; Kirik, D.; Kokaia, Z.; Lindvall, O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 2002, 8, 963-970.
15. Parent, J.M.; Vexler, Z.S.; Gong, C.; Derugin, N.; Ferriero, D.M. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann. Neurol. 2002, 52, 802-813.
16. Borlongan, C.V.; Hess, D.C. New hope for stroke patients: Mobilization of endogenous stem cells. CMAJ 2006, 174, 954-955.
17. Cui, X.; Chopp, M.; Shehadah, A.; Zacharek, A.; Kuzmin-Nichols, N.; Sanberg, D.; Dai, J.; Zhang, C.; Ueno, Y.; Roberts, C.; et al. Therapeutic benefit of treatment of stroke with simvastin and human umbilical cord blood cells: Neurogenesis, synaptic plasticity, and axon growth. Cell Transplant. 2012, 21, 845-856.
18. Rowe, D.; Leonardo, C.; Recio, J.; Collier, L.; Willing, A.; Pennypacker, K. Human umbilical cord blood cells protect oligodendrocytes from brain ischemia through Akt signal transduction. J. Biol. Chem. 2012, 287, 4177-4187.
19. Xiao, J.; Nan, Z.; Motooka, Y.; Low, W.C. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev. 2005, 14, 722-733.
20. Lee, J.; Hong, J.; Moon, G.; Lee, P.; Ahn, Y.; Bang, O. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patient with ischemic stroke. Stem Cells 2010, 28, 1099-1106.
21. Bang, O.; Lee, J.; Lee, P.; Lee, G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann. Neurol. 2005, 57, 874-882.
22. Li, L.; Jiang, Q.; Ding, G.; Zhang, L.; Zhang, Z.; Li, Q.; Panda, S.; Lu, M.; Ewing, J.; Chopp, M. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an mri study. J. Cereb. Blood Flow Metab. 2010, 30, 653-662.
23. Walczak, P.; Zhang, J.; Gilad, A.; Kedzioreck, D.; Ruiz-Cabello, J.; Young, R.; Pittenger, M.; van Zijl, P.; Huang, J.; Bulte, J. Dual modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008, 39, 1569-1574.
24. Kondziolka, D.; Steinberg, G.; Wechsler, L.; Meltzer, C.C.; Elder, E.; Gebel, J.; Decesare, S.; Jovin, T.; Zafonte, R.; Lebowitz, J.; et al. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J. Neurosurg. 2005, 103, 38-45.
25. Savitz, S.; Dinsmore, J.; Wu, J.; Henderson, G.; Stieg, P.; Caplan, L. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: A preliminary safety and feasability study. Cerebrovasc. Dis. 2005, 20, 101-107.
26. Hayase, M.; Kitada, M.; Wakao, S.; Itozaku, Y.; Nozaki, K.; Hashimoto, N.; Takagi, Y.; Dezawa, M. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J. Cereb. Blood Flow Metab. 2009, 29, 1409-1420.
27. Roybon, L.; Zhi, M.; Asztely, F.; Fosum, A.; Jacobsen, S.; Brundin, P.; Li, J. Failure of transdifferentiation of adult hematopoietic stem cells into neurons. Stem Cells 2006, 24, 1594-1604.
28. Harting, M.T.; Jimenez, F.; Adams, S.D.; Mercer, D.W.; Cox, C.S. Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy. Surgery 2008, 144, 803-813.
29. Liu, N.; Chen, R.; Du, H.; Wang, J.; Zhang, Y.; Wen, J. Expression of IL-10 and TNF-α in rats with cerebral infarction after transplantation with mesenchymal stem cells. Cell. Mol. Immunol. 2009, 6, 207-213.
30. Walker, P.; Harting, M.; Jimenez, F.; Shah, S.; Pati, S.; Dash, P.; Cox, C. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via NFκB-mediated increase in interleukin-6 production. Stem Cells Dev. 2010, 19, 867-876.
31. Fischer, U.; Harting, M.; Jimenez, F.; Monzon-Posadas, W.; Xue, H.; Savitz, S.; Laine, G.; Cox, C. Pulmonary passage is a major obstacle for intravenous stem cell delivery: The pulmonary first-pass effect. Stem Cells Dev. 2009, 18, 683-691.
32. Nemeth, K.; Leelahavinichkul, A.; Yuen, P.; Mayer, B.; Parmelee, A.; Doi, K.; Robey, P.; Leelahavinchkul, K.; Koller, B.; Brown, J.; et al. Bone marrow stromal cells attenuate sepsis via prostoglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 2009, 15, 42-49.
33. Lee, S.; Chu, K.; Jung, K.; Kim, S.; Kim, D.; Kang, K.; Hong, N.; Kim, J.; Ban, J.; Park, H.; et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008, 131, 616-629.
34. Neuhoff, S.; Moers, J.; Rieks, M.; Grunwald, T.; Jensen, A.; Dermietzel, R.; Meier, C. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. Exp. Hematol. 2007, 35, 1119-1131.
35. Seminatore, C.; Polentes, J.; Ellman, D.; Kozubenko, N.; Itier, V.; Tine, S.; Tritschler, L.; Brenot, M.; Guidou, E.; Blondeau, J.; et al. The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 2010, 41, 153-159.
36. Buhnemann, C.; Scholz, A.; Bernreuther, C.; Malik, C.; Braun, H.; Schachner, M.; Reymann, K.; Dihne, M. Neuronal differentiation of transplanted embryonic stem cell-derived precursors in stroke lesions of adult rats. Brain 2006, 129, 3238-3248.
37. Takagi, Y.; Takahashi, J.; Saiki, H.; Morizane, A.; Hayashi, T.; Kishi, Y.; Fukada, H.; Okamoto, Y.; Koyanagi, M.; Ideguchi, M.; et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a parkinson primate model. J. Clin. Invest. 2005, 115, 102-109.
38. Ideguchi, M.; Palmer, T.; Recht, L.; Weimann, J. Murine embryonic stem cell-derived pyramidal neurons integrate into the cerebral cortex and appropriately project axons to subcortical targets. J. Neurosci. 2010, 30, 894-904.
39. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
40. Yu, J.; Vodyanik, M.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.; Tian, S.; Nie, J.; Jonsdottir, G.; Ruotti, V.; Stewart, R.; et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
41. Pera, M. Stem cells: The dark side of induced pluripotency. Nature 2011, 471, 46-47.
42. Kawai, H.; Yamashita, T.; Ohta, Y.; Deguchi, K.; Nagotani, S.; Zhang, X.; Ikeda, Y.; Matsuura, T.; Abe, K. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J. Cereb. Blood Flow Metab. 2010, 30, 1487-1493.
43. Li, B.; Piao, C.-S.; Liu, X.-Y.; Guo, W.-P.; Xue, Y.-Q.; Duan, W.-M.; Gonzalez-Toledo, M.; Zhao, L.-R. Brain self-protection: The role of endogenous neural progenitor cells in adult brain after cerebral cortical ischemia. Brain Res. 2010, 1327, 91-102.
44. Wu, W.; Chen, X.; Hu, C.; Li, J.; Yu, Z.; Cai, W. Transplantation of neural stem cells expressing hypoxia-inducible factor-1alpha (HIF-1α) improves behavioral recovery in a rat stroke model. J. Clin. Neurosci. 2010, 17, 92-95.
45. Toda, H.; Takahashi, J.; Iwakami, N.; Kimura, T.; Hoki, S.; Mozumi-Kitamura, K.; Ono, S.; Hashimoto, N. Grafting neural stem cells improved the impaired spatial recognition in ischemic rats. Neurosci. Lett. 2001, 316, 9-12.
46. Menon, L.; Picinich, S.; Koneru, R.; Gao, H.; Lin, S.; Koneru, M.; Mayer-Kuckuk, P.; Glod, J.; Banerjee, D. Differentiation gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells. Stem Cells 2007, 25, 520-528.
47. Coyne, T.; Marcus, A.; Woodbury, D.; Black, I. Marrow stromal cells transplanted to the adult brain are rejected by an inflammatory response and transfer donor labels to host neurons and glia. Stem Cells 2006, 24, 2483-2492.
48. Willing, A.; Vendrame, M.; Mallery, J.; Cassady, C.; Davis, C.; Sanchez-Ramos, J.; Sanberg, P. Mobilized peripheral blood cells administeres intravenously produce functional recovery in stroke. Cell Transplant. 2003, 12, 449-454.
49. Serafini, M.; Dylla, S.; Oki, M.; Heremans, Y.; Tolar, J.; Jiang, Y.; Buckley, S.; Pelacho, B.; Burns, T.; Frommer, S.; et al. Hematopoietic reconstitution by multipotent adult progenitor cells: Precursors to long-term hematopoietic stem cells. J. Exp. Med. 2007, 204, 129-139.
50. Zhao, L.; Duan, W.; Reyes, M.; Keene, C.; Verfaille, C.; Low, W. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp. Neurol. 2002, 174, 11-20.
51. Burns, T.; Ortiz-Gonzalez, X.; Gutierrez-Perez, M.; Keene, C.; Sharda, R.; Demorest, Z.; Jiang, Y.; Nelson-Holte, M.; Soriano, M.; Nakagawa, Y.; et al. Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: A word of caution. Stem Cells 2006, 24, 1121-1127.
52. Damjanov, I. Teratocarcinoma stem cells. Cancer Surveys 1990, 9, 303-319.
53. Meissner, A.; Wernig, M.; Jaenisch, R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 2007, 25, 1177-1181.
54. Muller, F.; Snyder, E.; Loring, J. Gene therapy: Can neural stem cells deliver? Nat. Rev. Neurosci. 2006, 7, 75-84.
55. Liu, H.; Honmou, O.; Harada, K.; Nakamura, K.; Houkin, K.; Hamada, H.; Kocsis, J. Neuroprotection by PIGF gene-modified human mesenchymal stem cells after cerebral ischemia. Brain 2006, 129, 2734-2745.
56. Onda, T.; Honmou, O.; Harada, K.; Houkin, K.; Hamada, H.; Kocsis, J. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J. Cereb. Blood Flow Metab. 2008, 28, 329-340.
57. Cho, Y.J.; Song, H.S.; Bhang, S.; Lee, S.; Kang, B.G.; Lee, J.C.; An, J.; Cha, C.I.; Nam, D.H.; Kim, B.S.; et al. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J. Neurosci. Res. 2012, 90, 1794-1802.
58. Kim, J.Y.; Kim, D.H.; Kim, J.H.; Lee, D.; Jeon, H.B.; Kwon, S.J.; Kim, S.M.; Yoo, Y.J.; Lee, E.H.; Choi, S.J.; et al. Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-b plaques. Cell Death Differ. 2012, 19, 680-691.
59. Kim, J.Y.; Kim, D.H.; Kim, J.H.; Yang, Y.S.; Oh, W.; Lee, E.H.; Chang, J.W. Umbilical cord blood mesenchymal stem cells protect amyloid-b42 neurotoxicity via paracrine. World J. Stem Cells 2012, 4, 110-116.
60. Van Koppen, A.; Joles, J.A.; van Balkom, B.W.M.; Lim, S.K.; de Kleijn, D.; Giles, R.H.; Verhaar, M.C. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One 2012, 7, e38746.
61. Ionescu, L.; Byrne, R.N.; van Haaften, T.; Vadivel, A.; Alphonse, R.S.; Rey-Parra, G.J.; Weissman, G.; Hall, A.; Eaton, F.; Thebaud, B. Stem cell conditioned medium improves acute lung injury in mice: In vivo evidence for stem cell paracrine action. Am. J. Physiol. Lung Cell. Mol. Physiol. 2012, 303, L967-L977.
62. Moniche, F.; Gonzalez, A.; Gonzalez-Marcos, J.R.; Carmona, M.; Pinero, P.; Espigado, I.; Garcia-Solis, D.; Cayuela, A.; Montaner, J.; Boada, C.; et al. Intra-arterial bone marrow mononuclear cells in ischemic stroke: A pilot clinical trial. Stroke 2012, 43, 2242-2244.